Table 1. Transcription and translation coordinates, timing of expression, and function of latent, early lytic and delayed early lytic ORFs.
Gene | Str | TSS-PolyA | Start-Stop | Ann | Variant | Timing | Function | Ref |
ORFK1 | + | 38–2956 | 105–959 | P | Latent | Glycoprotein | [89] | |
ORF4 | + | 1097–2956 | 1127–2779 | P | Sp.Var | 24 h | Complement binding protein | [90] |
ORF6U | + | 3137–7013 | 3194–6592 | P | 24–48 h | ssDNA Binding protein | [91] | |
ORF11U | + | 15610–17054 | 15771–16994 | P | 8 h | Predicted dUTPase | [92] | |
vIL6U | − | 17960–17163 | 17856–17242 | P | Latent | viral Interleukine 6 homolog | [93] | |
ORFK3 | − | 21099–18575 | 19557–18589 | P | Internal | 24 h | Immune modulator | [94], [95] |
ORF70 | − | 21099–18575 | 21051–20038 | P | Alt. Start | 8 h | thymidylate synthasee | [96] |
ORFK4 | − | 21898–21274 | 21779–21495 | P | 8 h | vMIP-II | [97] | |
ORFK4.1 | − | 22864–21274 | N/A | P | 8 h | N/A | ||
1.4 kb | + | 24175–25394 | multiple | P | 8 h | N/A | [28] | |
ORFK5U | − | 26692–25501 | 26433–25663 | P | 8 h | RING-CH E3 Ubiquitin ligase | [94], [95] | |
ORFK6 | − | 27472–26843 | 27374–27422 | P | Alt. Start | 8 h | vMIP-IA | [94], [95] |
PAN | + | 28616–29690 | multiple | P | 8 h | Late gene expression | [33], [38] | |
ORF16 | + | 29770–30566 | 29962–30489 | P | 8 h | Bcl2 homolog | [98], [99] | |
ORF17.5 | − | 31536–30563 | 31505–30639 | P | 24 h | Assembly protein | [100] | |
ORF18 | + | N/A-33273 | 32242–33015 | P | 24 h | Late gene regulationMHV68 | [101] | |
ORF34U | + | 54379–58691 | 54491–55474 | M | 24 h–48 h | N/A | [102] | |
ORF35U | + | 55381–58691 | 55455–55907 | M | 24 h–48 h | N/A | [103] | |
ORF36 | + | N/A-58691 | N/A-57126 | M | 24 h–48 h | Serine protein kinase | [104] | |
ORF37U | + | N/A-58691 | 57089–58549 | M | 24 h–48 h | Sox | [50] | |
ORF38U | + | 58186–58691 | 58504–58689 | P | 24 h–48 h | Myristylated protein | [61] | |
ORF39 | − | 60050–58701 | 59991–58789 | P | 24 h–48 h | Glycoprotein M | [105] | |
ORF45U | − | 68683–67140 | 68392–67169 | P | 8 h | RSK activator | [106] | |
ORF46 | − | 69782–67140 | 69220–68453 | P | 24 h | Uracil deglycosylase | [107] | |
ORF47U | − | 69782–67140 | 69731–69228 | M | 24 h | glycoprotein L | [96], [108] | |
ORF50 | + | 71374–76554 | 71412–74445 | P | AS-ORF | 8 h | RTA | [109] |
ORFK8 | + | 74660–76554 | 74675–75607 | P | Sp. Var | 8 h–24 h | bZIP | [110] |
ORF57 | + | 81819–83453 | 81886–83361 | P | Sp. Var | 8 h | mRNA export/splicing | [61] |
ORF58 | − | 96613–94287 | 95363–94290 | P | 24 h | N/A | [61] | |
ORF59 | − | 96613–94287 | 96558–95368 | P | 24 h | Processivity factor | [61], [62] | |
ORF60 | − | 100149–94287 | 97606–96689 | P | 24 h–48 h | Ribonucleoprotein reductase | [61] | |
ORF61U | − | 100149–94287 | 100013–97635 | P | 24 h–48 h | Ribonucleoprotein reductase | [61] | |
ORFK12 | − | 119205–117250 | 119075–117738 | P | Alt. Start | Latent | Kaposin | [111] |
ORF71 | − | 124220–122513 | 123154–122588 | M | Latent | vFLIP | [112] | |
ORF72U | − | 124220–122513 | 124010–123236 | M | Latent | vCyclin | [112] | |
ORF73 | − | 128213–122513 | 127623–124252 | M | Latent | LANA | [112] |
Transcription and translation coordinates for the primary viral ORFs were annotated from in silico predictions and/or by manually curating mRNA-seq and Ribo-seq data. Timing was determined according to the time of transcription. Functions were gathered from the literature. U: uORF in leader region; Str: Strand; TSS: transcription start site; N/A, not determined in silico or by manual annotation; Ann: Annotation; P: predicted; M: manual annotation; Sp. Var: ORF with splice variant, Alt. Start: ORF with alternative starts; Internal: ORF with internal ORFs; AS-ORF: Antisense ORFs; MHV68: Function annotated in MHV68.